BI
BMY icon

Bredin Investment’s Bristol-Myers Squibb BMY Stock Holding History

Bredin Investment’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		$2.03M Hold
31,586
– – 1.66% 17
2019
Q3 		$1.6M Hold
31,586
– – 1.4% 18
2019
Q2 		$1.4M Hold
31,586
– – 1.22% 22
2019
Q1 		$1.51M Hold
31,586
– – 1.32% 17
2018
Q4 		$1.64M Hold
31,586
– – 1.55% 13
2018
Q3 		$1.96M Hold
31,586
– – 1.6% 12
2018
Q2 		$1.75M Hold
31,586
– – 1.34% 15
2018
Q1 		$2M Hold
31,586
– – 1.73% 12
2017
Q4 		$1.94M Buy
+31,586
New +$1.98M 1.56% 14

Other funds holding BMY

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Bredin Investment's BMY Position: Q4 2019 in Review

Bredin Investment held its Bristol-Myers Squibb (BMY) position steady in Q4 2019 at 31,586 shares worth $2.03M. The position accounts for 1.66% of the portfolio, ranked #17.

Bredin Investment first reported a position in BMY in Q4 2017 and has held it in 9 quarters since. 2,218 funds tracked by Wall St. Rank hold BMY as of Q4 2019.

  • Bredin Investment held 31,586 shares of Bristol-Myers Squibb worth $2.03M as of Q4 2019.
  • Bredin Investment left its Bristol-Myers Squibb share count unchanged in Q4 2019.
  • Bristol-Myers Squibb made up 1.66% of Bredin Investment's portfolio in Q4 2019, its #17 holding.
  • Bredin Investment first reported a position in Bristol-Myers Squibb in Q4 2017 and has held it in 9 quarters since.
  • 2,218 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q4 2019.

Based on Bredin Investment's 13F filing for Q4 2019, filed 6 Feb 2020.